Hi Nigel,
Eva here from Scotland. I think some of the older drugs are a bit cheaper: for example, Thal is cheaper than Rev. I'm sure that Nice will fight to save money. In the end treatments become available when they've been used in other countries for ages and it becomes obvious that we are very backward in funding them.
One of my neighbours who was a surgeon and a psychiatrist died recently of kidney cancer. She was refused a drug that can be accessed in other countries. Of course, she would have died anyway but she might have lasted longer.
In the US people who have very good insurance might get better treatment and those who don't and have very little money can benefit from various schemes to assist them. There is a group of people in the middle who are really struggling though and who have to come up with massive 'co-pays' each month. Some of them have had to sell their homes or use up their childrens' inheritance. I've had medical insurance here for at least ten years. I had a chat with my insurance company and told them about my myeloma. They are very very keen for me to use the NHS for all treatments. When I gave some reasons for going private, at least at times, they said they were prepared to fund one second opinion in London as I live in a more sparsely populated area.This was for the consultation, and not for treatment. The person in charge of my 'case' implied that any attempt to get treatment on the policy would be met by very very rigorous procedures. In the end I was told that there would have to be no NHS treatment available. I always thought that insurance gave us an entitlement to private treatment if that was our choice. I've been paying over a hundred pounds a month for my policy for many years and have continued it even though I've had to stop working. I think it's unfortunate that an insurance company is determined to not lose any money even if someone has a condition as complex as myeloma. Good luck with your Velcade treatment – I haven't had Velcade yet as I was diagnosed almost three years ago.
Best,
Eva